Swing Trade Ideas

🏃🚀✅  AEHL high 2.40 up 71%  🚀 

🏃🚀✅  SIDU high 3.12 up   🚀 

🏃🚀✅  CGC high 2.28, up 33%  🚀 

🏃🚀✅   AKAN high 1.05, up 50%    🚀 

🏃🚀✅ YCBD 2.53 high :rocket: 110% 🚀 

🏃🚀✅  VERO high 2.86, up 59  🚀 

🏃🚀✅  SIDU high 1.23, up 64%  🚀 

 ✅ $SAVA Entry: $1.95 – $2.00

🎯 PT1: $2.10 – $2.50, 🎯 PT2: $2.60 – $2.90, 🎯 PT3: $3.00 – $3.70

🚫 Stop: Below $1.80 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 CEO recently acquire shares, company focuses on developing novel treatments and diagnostics for neurogenerative diseases, especially Alzheimer's disease 

✅ $SPRC Entry: $1.30 – $1.35

🎯 PT1: $1.60 – $2.10, 🎯 PT2: $2.20 – $2.90, 🎯 PT3: $3.00 – $3.70

🚫 Stop: Below $1.20 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 Recently announced NeuroThera labs secured Israel patent for opioid PEA combination aimed at enhancing pain relief while reducing opioid side effects, announced to acquire 55% stake in quantum computing bio data company, Launched Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery, company focuses on developing therapies for disorders of the central nervous system , recent 1/21 reverse split 

✅ BYND Entry: 0.80 – 0.85

🎯 PT1: 1.20 – 1.90, 🎯 PT2: 2.05 – 3.80, 🎯 PT3: 3.90 – 4.50

🚫 Stop: Below 0.70 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

  back to support from recently high, recently launched latest Beyond Burger at Hard Rock Cafe and introduced Beyond Beef at retailers across Canada, company produces plant-based meat alternatives, does have mixed shelf, be mindful on next spike 

✅ VERO Entry: 1.60

🎯 PT1: 1.80 – 2.50, 🎯 PT2: 2.60 – 3.4, 🎯 PT3: 3.50 – 4.20

🚫 Stop: Below 1.55 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical setup

 Back to 52wk  low, small float, recently gained FDA clearanced for Nevus Nova, previous entered consent agreement with Madryn Health,  13D filing shows Madryn Asset Management acquires 85.5% stake, recently entered unit purchase agreement with $META robotics and Mhg, also recently announced to sell hair transplant business to Meta Healthcare in $20m all cash deal, company focuses in minimally invasive and non-invasive aesthetic and hair-restoration devices 

 ✅ CGC Entry: $1.15 – $1.20

🎯 PT1: $1.50 – $1.9, 🎯 PT2: $2.00 – $2.7, 🎯 PT3: $2.80 – $3.70

🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

  CGC another risk and repeat, potential swing 1.1/1.20, stop if below 1 or daily max risk per trade @here mj ticker , one of the largest Canadian cannabis companies focuses on production, distribution, and sale of medical and recreational cannabis, also carries non-THC products including hemp-derived wellness goods 

 ✅ UAVS Entry: $0.80 – $0.85

🎯 PT1: $1.20 – $1.5, 🎯 PT2: $1.60 – $2.2, 🎯 PT3: $2.30 – $3.20

🚫 Stop: Below $0.70 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical setup

 near 52w low , recently delivered First eBee X manufacturing kits to Vyom drones, marking milestone toward local production in India, previously sold eBee VISION Drones to U.S Army in Germany, partnered wit Makville to bring drones to Egypt, company designs and delivers unmanned aerial system including drones, sensors, software and data analytics solutions globally for commercial, government, agricultural, energy, infrastructure, and defense applications, does have mixed shelf, be mindful on next spike  

 ✅ MRKR potential entry: $1.30 – $1.40

🎯 PT1: $1.80 – $2.50, 🎯 PT2: $2.60 – $2.7, 🎯 PT3: $2.80 – $3.40

🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 near 52wk low,recently announced positive APOLLO study, recently partnered with Cellpont for MT-601 Manufacturing, company focuses on developing novel T-cell therapies for hematological malignancies and solid tumors, HC Wainwright price target $10, WBB Securities price target $12.50, Canaccord Genuity buy rating price target $8, Brookline buy rating, 

✅ CRDL potential entry: $0.85 – $0.95

🎯 PT1: $1.30 – $1.8, 🎯 PT2: $1.90 – $2.6, 🎯 PT3: $2.70 – $3.50

🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 near 52wk low , recently announced positive phase II ARCHER Trial data for CardioIRx, recently secured USA patent for hear drugs, company focuses on novel anti-inflammatory and anti-fibrotic therapies for heart disease, its lead drug, CardioIRx (an oral cannabidiol formulation) is designed to treat serious cardiac conditions like acute myocarditis and recurrent pericarditis by modulating inflammatory pathways involved in fibrosis and heart damage.  First Berlin Equity Research price target $7.80, Canaccord Genuity buy rating, HC Wainwright price target $9, does have mixed shelf 

  ✅ ACRV Entry: $2.25 – $2.35

🎯 PT1: $2.50 – $2.90, 🎯 PT2: $3.00 – $3.80, 🎯 PT3: $3.90 – $4.40

🚫 Stop: Below $2.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 upcoming catalyst: 1) clinical data for ACR-368 and ACR-2316 January 2026, company focuses on oncology, use a proprietary proteomics/phosphoproteomics platform (AP3) to match tumor's signaling pathways to drug mechanisms, Citizens JMP buy rating, Oppenheimer price target $8, Piper Sandler buy rating, 

✅ GTBP Entry: $0.70 – $0.80

🎯 PT1: $1.30 – $1.80, 🎯 PT2: $2.00 – $2.6, 🎯 PT3: $2.70 – $3.30

🚫 Stop: Below $0.60 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 recently announced advancing phase 1 trial of GTB-3650 for relapsed blood cancers, update data expecting Q1 2026, other upcoming catalysts: 1) submission for GTB-5550 trial expected January 2026, have until May 16, 2026 to regain compliance, company develops cancer therapies using proprietary TriKE platform, designed to activate natural killer cells to attack cancer cells, ROTH MKM price target $8, does have mixed shelf, be mindful on next spike, keep current support .60 as bottom stop loss 

✅ AEHL Entry: $1.30 – $1.40

🎯 PT1: $2.70 – $3.5, 🎯 PT2: $3.60 – $4.2🎯 PT3: $4.30 – $4.8, 🚫 Stop: Below $1.10 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast-moving | Technical setup

 back to support form recent high above 3, previously signed cooperative agreement with BitGo to advance $BIT.X acquisition and security, company focuses on livestream e-commerce, digital/social commerce services, and consulting through its subsidiaries, subsidiaries include a 51% ownership of Hainan Kylin Cloud, does have mixed shelf, be mindful on next spik 

✅ VTAK Entry: $1.75 – $1.80

🎯 PT1: $2.40 – $2.80
🎯 PT2: $3.00 – $3.60
🎯 PT3: $3.70 – $4.30

🚫 Stop: Below $1.50 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical setup

 back to near 52wk low from recent high above $4.30, small float, recently entered distribution agreement with FuMedica, and announced two patents to be issued by USPTO, previously received Approval for LockeT in the United Kingdom, announced introduction of LockeT product line into Italy, company specializes in medical device based in US, two main products: VIVO system is a non-invasive, ED cardiac mapping system that integrates ECG and imaging data to help localize ventricular arrhythmia origins before procedures, the other is LockeT device, a suture retention tool designed to optimize vascular closure after percutaneous procedures, aiming to speed up hemostasis and patient recovery,  does have mixed shelf, 

✅ KULR Entry: $3.55 – $3.65

🎯 PT1: $3.90 – $4.5, 🎯 PT2: $4.60 – $5.2, 🎯 PT3: $5.30 – $5.80

🚫 Stop: Below $3.30 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 recently entered join development collaboration for battery backup unit for $100M, joined Open compute project as platinum member, company develops and commercializes thermal management technologies focused on battery safety, heat dissipation and energy/system solutions 

✅ KTTA Entry: $1.05 – $1.15

🎯 PT1: $1.30 – $1.80, 🎯 PT2: $1.90 – $2.60, 🎯 PT3: $2.70 – $3.30

🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

  back to support from recent high above 2, recent offering $.75/share, CEO Tiago Marques reported acquisition of shares, company focused on researching and developing treatments for central nervous system (CNS) disorders, neurological conditions, RASopathies, and certain cancers,  HC Wainwright price target $3, 

 ✅ HOTH Entry: $1.05 – $1.10

🎯 PT1: $1.40 – $1.80
🎯 PT2: $1.90 – $2.50
🎯 PT3: $2.60 – $3.00

🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade

 presenting at the Noble Capital Markets Annual conference Dec 2-3, recently accepted into $NVDA Connect Program to accelerate AI-driven drug development, previously partnered and expanded its AI Initiative through $NVDA AI enterprise subscription license, previously entered joint venture with $SILO Pharma to commercialize VA-invented obesity Drug, expanded phase II clinical trial for HT-001, topical gel treating skin toxicities, across Europe in collaboration with ICON, recent data demonstrated significant reduction in tumor growth, announced patent to develop anti-obesity treatments with US Depart. Of Veterans Affairs, also previously purchased up to $1M of $BTC.X as treasury reverse asset, upcoming catalysts: 1) IND filing for HT-KIT, which recently announced positive data, suppressing tumor growth in preclinical models, expected to submit early 2026, 2) upcoming presentation to highlight advancements in clinical pipeline at the upcoming BIO -Europe 2025 conference, November 3-5 in Vienna, Austria D. Boral capital price target $5, HC Wainwright price target $4 

✅ PRSO Entry: $0.85 – $0.90

🎯 PT1: $1.20 – $1.70
🎯 PT2: $1.80 – $2.50
🎯 PT3: $2.60 – $3.20

🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 recently announced collaboration with Virewirx, previously secured $1.1M through inducement offer agreement, ,secured $0.9M order from FWA equipment supplier, partnered with WeLink to expand access to high-speed broadband across dense US metro areas, company focuses on fabless semiconductor/mmWave wireless technology, , Benchmark Co buy rating, price target $3, 

✅ LNAI Entry: $0.95 – $1.00

🎯 PT1: $1.20 – $1.80
🎯 PT2: $1.90 – $2.70
🎯 PT3: $2.80 – $3.70

🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

 recently identified three Parkinson's disease subtypes and drug targets to accelerate therapeutic development, also recently secured first letter of intent for its immune cell therapy, launched transformer-base platform to secure GenAI, partnered with American Defense International to enhance US. Biodefense capabilities , company is a pre-clinical biotech and AI-powered drug discovery company focused on developing of therapeutics and vaccines, AI-driven diagnostic platforms, and biodefense 

✅ RUBI Entry: $1.35 – $1.45

🎯 PT1: $1.70 – $2.30
🎯 PT2: $2.40 – $3.30
🎯 PT3: $3.40 – $4.20

🚫 Stop: Below $1.30 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

 back to near 52wk low, recently signed letter of intent to acquire newbuilding mega Yacht, recent 1/30 reverse split, ultra small float <1m, international shipping company operating in the marine transportation sector 

 ✅ IMCC Entry: $1.70 – $1.75

🎯 PT1: $2.00 – $2.50, 🎯 PT2: $2.60 – $3.30, 🎯 PT3: $3.40 – $3.90

🚫 Stop: Below $1.50 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

 MJ related tickers, recently signed term sheet to acquire 60% stake in Quantum computing bio data company co for up to $54M, company produces and distributes medical cannabis products 

✅ GRWG Entry: $2.20 – $2.25

🎯 PT1: $2.50 – $2.90
🎯 PT2: $3.00 – $3.50
🎯 PT3: $3.60 – $4.50

🚫 Stop: Below $2.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical setup

 MJ related tickers, Lake Street buy rating, company is a specialty retail supplier of hydroponic and organic gardening equipment and products used by commercial and hobby growers, operate retail and distribution centers across US. 

 ✅ SNDL entry: $2.00 – $2.10

🎯 PT1: $2.40 – $2.80, 🎯 PT2: $2.90 – $3.50, 🎯 PT3: $3.60 – $4.40

🚫 Stop: Below $1.90 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 MJ related ticker, recently amended agreement to acquire Cannabis Retail stores, company produces, distributes, and sells cannabis products, analyst rating price target $5 

✅ AKAN entry: $0.70

🎯 PT1: $1.20 – $1.8,🎯 PT2: $1.90 – $2.5, 🎯 PT3: $2.60 – $3.40

🚫 Stop: Below $0.65 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 MJ related ticker, recently announced advancing towards full cultivation license in Canada, announced major expansion of cellular Network in Mexico, company is a medical cannabis cultivation, manufacturing and distribution space, operates in international markets 

 ✅ RZLT entry: $1.50 – $1.60

🎯 PT1: $1.80 – $2.40, 🎯 PT2: $2.60 – $3.50, 🎯 PT3: $3.60 – $4.10

🚫 Stop: Below $1.20 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast-moving | Technical setup

 recently drop over 90% from near 52wk high to near 52wk low on fail phase 3 data, Maxim price target $4, Guggenheim $6, still buy rating, HC Wainwright $5, Jefferies price target $4, BTIG price target $5, analysts price lowered after failed data, company focuses on rare metabolic and hypoglycemia disorders 

✅ YCBD potential entry: $1.10 – $1.20

🎯 PT1: $1.50 – $2.30, 🎯 PT2: $2.40 – $3.3, 🎯 PT3: $3.40 – $3.80

🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast-moving | Technical setup

 recently announced regained NYSE compliance, recently entered partnership with Bevtalk distribution to expand herbal Oasis THC Selzer distribution across Florida, US based consumer wellness company focuses on CBD and hemp-derived products, have distribution channel via DTC online, $AMZN and retail partners, Maxim group by rating 

 ✅  CRON entry: $3.05 – $3.10

🎯 PT1: $3.50 – $3.90, 🎯 PT2: $4.00 – $4.50, 🎯 PT3: $4.60 – $5.50

🚫 Stop: Below $2.95 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 MJ ticker, focuses on cultivation, production, distribution for medical and adult use markets 

✅ CGC entry: $1.40 – $1.50

🎯 PT1: $1.80 – $2.50, 🎯 PT2: $2.60 – $3.70, 🎯 PT3: $3.80 – $4.70

🚫 Stop: Below $1.20 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 one of the largest Canadian cannabis companies focuses on production, distribution, and sale of medical and recreational cannabis, also carries non-THC products including hemp-derived wellness goods 

 ✅ SPRC entry: $1.80 – $1.90
🎯 PT1: $2.40 – $3.1, 🎯 PT2: $3.20 – $3.9,🎯 PT3: $4.00 – $4.70
🚫 Stop: Below $1.70 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup 

 back to support from recent high, recently announced to acquire 55% stake in quantum computing bio data company, Launched Innovative Quantum Computing-Enabled 3D Protein Modeling Initiative to Revolutionize AI Drug Discovery, company focuses on developing therapies for disorders of the central nervous system , recent 1/21 reverse split, 

 ✅ VCIG entry: $0.85
🎯 PT1: $1.10 – $1.80, 🎯 PT2: $1.90 – $2.50, 🎯 PT3: $2.60 – $3.40
🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast Moving | Technical Setup 

 back to 52wk low from recent high above 1.70, recent 1/30 reverse split, recently awarded $200M RWA consultancy mandate, acquired ~4M additional OOB tokens at, also recently partnered with Oobit to expand access to global payment market, CEO recently incease stake, purchased shares on open market, company focuses on strategy consultancy, technology development 

 ✅ NRSN entry: $0.83 – $0.87
🎯 PT1: $1.30 – $1.90, 🎯 PT2: $2.00 – $2.70, 🎯 PT3: $2.80 – $3.50
🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup 

 back to near 52wk low, recently announced positive trial results for Alzheimer's drug candidate, D. Boral Capital price target $14, Noble financial buy rating, Alliance Global Partners buy rating,  its leading drug candidate, PrimeC, a combination of ciprofloxacin and celecoxib for amyotrophic lateral sclerosis (ALS) has shown positive clinical data in phase 2b, currently being prepared for commercial-scale production, upcoming catalyst: 1) topline data, phase 3, 2nd of half 2025, 2) full lNDS submission later of 2025, 3) phase 2 alzheimer's trial top line expected 2026, company focuses on neurodegenerative diseases, primarily ALS, with additional pipeline programs targeting Alzheimer's and Parkinson's 

 ✅ XTKG entry: $1.50 – $1.60
🎯 PT1: $2.00 – $2.40, 🎯 PT2: $2.50 – $3.20, 🎯 PT3: $3.30 – $3.80
🚫 Stop: Below $1.20 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🔴 High | Fast moving | Technical Setup 

 recently acquired creation intelligent to boost gaming portfolio, company focuses on digital solutions and technology, operating across four primary segments: digital technologies, crypto mining, renewable energy, and Argi-tech, DOES have active mixed shelf, be mindful on next spike 

 ✅ VERO entry: $1.80–$1.90
🎯 PT1: $2.40–$2.90, 🎯 PT2: $3.10–$3.45, 🎯 PT3: $3.55–$4.2, 

🚫 Stop: Below $1.70 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

Back to 52wk low, small float, recently gained FDA clearanced for Nevus Nova, previous entered consent agreement with Madryn Health, 13D filing shows Madryn Asset Management acquires 85.5% stake, recently entered unit purchase agreement with $META robotics and Mhg, also recently announced to sell hair transplant business to Meta Healthcare in $20m all cash deal, company focuses in minimally invasive and non-invasive aesthetic and hair-restoration devices

 ✅ APM entry: $1.25–$1.35
🎯 PT1: $1.80–$2.30, 🎯 PT2: $2.40–$2.90, 🎯 PT3: $3.00–$3.50
🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade
🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup 

 recently unveiled new plasma microRNA biomarket data at Alzheimer's conference,  recently announced merger with DiamiR Bioscience, aiming to advance brain health solutions, expected to close Q4 2025, company focuses on targeting disease with unmet medical needs in oncology and infectious diseases. 

 ✅ SCNX entry: $0.50 – $0.60
🎯 PT1: $0.80 – $1.40, 🎯 PT2: $1.50 – $1.80, 🎯 PT3: $1.90 – $2.50

🚫 Stop: Below $0.45 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 back to near 52wk low, participate in iAccess Alpha conference Dec 9-10, recently announced shipment of ARBLI, the first FDA-approved ready to use liquid losasrtan to tis distribution center, marking major commercialization milestones, Arbli is the first and only FDA-approved ready-to-use oral liquid losartan available in the United States, designed to treat hypertension in patients over six years old, reduce stroke risk in patients with hypertension and left ventricular hypertrophy, and treat diabetic nephropathy in certain patients with type 2 diabetes, does have active mixed shelf, be mindful on next spike, 

✅ MRM entry: $2.00 – $2.05
🎯 PT1: $2.40 – $2.80, 🎯 PT2: $2.90 – $3.40, 🎯 PT3: $3.50 – $3.90

🚫 Stop: Below $1.80 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 back support from recent high above 4, recently partnerships with TD Synnex to expand nationwide distribution of Smart Health Devices, previously announced launching new treasury strategy using cryptocurrency, previously announced more than 10,000 people received verified World IDS at $MRM locations, recent partnership announcement with World, co-founded by Sam Altman to double deployment of Orb Human authentication device across Japan, company is a Japan-based holistic healthcare, does have mixed shelf, be mindful on next spike, 

 ✅ SIDU entry: $0.70 – $0.75

🎯 PT1: $1.20 – $1.80, 🎯 PT2: $2.00 – $2.70, 🎯 PT3: $2.80 – $3.90

🚫 Stop: Below $0.60 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 back to near support from recent high, recent offering price $1.0 share, recently won subcontractor role on NASA radar design study, also advanced orbital debris tracking with LIzzieSat Radar Integration, completed its NASA phase II sequential award with Xiomas Technologies, recently unveiled Edge computing breakthrough for real0time fire detection, previously awarded FIVE-YEAR $21 M contract under the Tobyhanna Army Depot (TYAD) industrial multiple award task order contract (MATOC) program for fabrication and on-call services for critical components used in TYAD'S operation 

✅ XTIA entry: $1.30 – $1.40

🎯 PT1: $1.60 – $2.40, 🎯 PT2: $2.50 – $2.80, 🎯 PT3: $2.90 – $3.30

🚫 Stop: Below $1.10 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 back to support from recent high above 2 on offering announcement, price at 1.60,  recent partnership announcement with Valkyrie to develop Vanguard platform, an intelligent technology system for the next generation of vertical takeoff and landing aircraft, recently selected Garmin G700 TXi Avionics for TriFan 600 xVTOL Aircraft,  company is an aviation/air-mobility focused, Maxim group buy rating 

 ✅ MVST entry: $3.50 – $3.60

🎯 PT1: $3.80 – $4.50, 🎯 PT2: $4.60 – $5.30, 🎯 PT3: $5.40 – $6.00

🚫 Stop: Below $3.40 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 back to support from recent high above 7, recently raised 2025 gross market outlook to 35% while advancing all-solid-state battery and European partnership , company designs, develops and manufactures advanced lithium-ion battery technologies from core cell materials to full battery packs and energy-store systems, their batteries are used for electric commercial vehicles (buses, trucks, specialty vehicles), heavy duty transportation, and utility-scare energy storage systems, analysts strong buy rating, target price $6, 

✅ ARBE entry: $1.45 – $1.55

🎯 PT1: $1.80 – $2.50, 🎯 PT2: $2.60 – $3.20, 🎯 PT3: $3.30 – $3.70

🚫 Stop: Below $1.20 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 back to near support from recent high above 2.50,  company develops 4D imaging radar chipsets and perception radar solutions for automotive, drones, industrial and robotics markets, company attempts to target a global market in automotive OEMS, tier-1 auto suppliers, autonomous/commercial vehicles, robotics, even drones, Canaccord Genuity buy rating, Roth MKM buy rating 

 ✅ ENLV entry: $1.0 $01.05

🎯 PT1: $1.20 – $1.70, 🎯 PT2: $1.80 – $2.60, 🎯 PT3: $2.70 – $3.80

🚫 Stop: Below $0.80 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 Recently closed $212M private placement, expanding digital asset strategy, adopts RAIN token treasury strategy and advances Allocetra knee osteoarthritis program, recently announced positive 6-month topline data, demonstrating durable and persistent pain reduction and improved function in primary age-rated patients with mod to severe knee osteoarthritis, company focuses on immunotherapy, main program is Allocetra, an off the shelf macrophage-reprogramming therapy intended to restore macrophages to healthy state, treating inflammatory and degenerative disease,  HC Wainwright price target $7, 

✅ LAZR entry: $0.80-.85

🎯 PT1: $1.05 – $1.50, 🎯 PT2: $1.60 – $2.20, 🎯 PT3: $2.30 – $2.70

🚫 Stop: Below $0.75 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 LAZR potential  swing .80, stop if below .75 or daily max risk per trade @here near 52wk low from recent high , company develops LiDAR hardware and perception software for autonomous vehicles, MarketBeat consensus price target $8, Zacks upgraded to buy, 

⏳ SMS swing alert: EDBL potential entry: $1.10 – $1.18

🎯 PT1: $1.50 – $2.00, 🎯 PT2: $2.10 – $2.90, 🎯 PT3: $3.00 – $3.60

🚫 Stop: Below $1.05 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 back to near 52wk low from recent high, recentl announced availability at Dumbo Market, Marrazzo's Market, previously started shipping Fresh Potted and cut herbs to $KR, also recently launched Kick Sports Nutrition Bundle at PriceSmart Warehouse Clubs, expanded USDA Organic offerings to Angelo Caputo's Fresh markets previously expanded Pickle Party line through new retail placements, small float, recently announced its Kick, sports nutrition won 2025 Mindful Award Sports Nutrition "Product of the Year", which launched on $AMZN , also announced expansion of retail footprint across Northeast, company focused on growing organic herbs, lettuces and plant-based protein products using innovative greenhouse, hydroponic and vertical farming methods, 

⏳ SMS swing alert: ✅ SBGX entry: $3.05 – $3.15

🎯 PT1: $3.50 – $3.80, 🎯 PT2: $4.90 – $5.50, 🎯 PT3: $6.60 – $7.40

🚫 Stop: Below $3.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 back to support from recent high above 9, recently announced shifting focus to energy, exited homebuilding to boost shareholder value 

⏳ SMS swing alert: VCIG potential entry: $1.00 – $1.05

🎯 PT1: $1.30 – $1.80, 🎯 PT2: $1.90 – $2.50, 🎯 PT3: $2.60 – $3.40

🚫 Stop: Below $0.90 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🔴 High | Fast moving | Technical Setup

 recent 1/30 reverse split, back to key support from recent high above 3.50, back to near 52wk low, recently acquired ~4M additional OOB tokens at, also recently partnered with Oobit to expand access to global payment market, CEO recently incease stake, purchased shares on open market, company focuses on strategy consultancy, technology development 

✅ HOTH potential entry: $1.05 – $1.15

🎯 PT1: $1.40 – $1.80, 🎯 PT2: $1.90 – $2.50, 🎯 PT3: $2.60 – $3.00

🚫 Stop: Below $1.00 or 2%–5% or daily max risk per trade

🚦 Risk Level: 🟡 Medium | Catalyst-Driven | Technical Setup

 presenting at the Noble Capital Markets Annual conference Dec 2-3, recently accepted into $NVDA Connect Program to accelerate AI-driven drug development, previously partnered and expanded its AI Initiative through $NVDA AI enterprise subscription license, previously entered joint venture with $SILO Pharma to commercialize VA-invented obesity Drug, expanded phase II clinical trial for HT-001, topical gel treating skin toxicities, across Europe in collaboration with ICON, recent data demonstrated significant reduction in tumor growth, announced patent to develop anti-obesity treatments with US Depart. Of Veterans Affairs, also previously purchased up to $1M of $BTC.X as treasury reverse asset, upcoming catalysts: 1) IND filing for HT-KIT, which recently announced positive data, suppressing tumor growth in preclinical models, expected to submit early 2026, 2) upcoming presentation to highlight advancements in clinical pipeline at the upcoming BIO -Europe 2025 conference, November 3-5 in Vienna, Austria D. Boral capital price target $5, HC Wainwright price target $4